GeneDx Holdings Corp. (WGS)
90.68
-1.36
(-1.48%)
USD |
NASDAQ |
Feb 19, 16:00
91.13
+0.45
(+0.50%)
After-Hours: 05:42
GeneDx Holdings Research and Development Expense (Quarterly) : 19.59M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Illumina, Inc. | 238.00M |
| Guardant Health, Inc. | 89.96M |
| Quest Diagnostics, Inc. | -- |
| Labcorp Holdings, Inc. | -- |
| Natera, Inc. | 173.41M |